Relmada Therapeutics Inc

NASDAQ RLMD

Data sourced from iex and EODHD
Download Data

Relmada Therapeutics Inc Income Statement 2011 - 2024

This table shows the Income Statement for Relmada Therapeutics Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M - - - - - - - - - - - - - - - - - - 3 6 8 10 8 7 7 7 7 6 4 2 - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Selling, General, and Administrative Expenses (SG&A)
M 46 49 49 45 47 48 45 45 40 35 32 29 28 25 22 18 11 7 7 6 6 5 4 4 5 6 5 6 7 7 9 10 9 9 8 9 11 8 6 3 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 52 55 67 87 104 113 112 115 102 91 80 57 45 36 23 13 11 8 7 7 5 5 4 3 2 1 1 1 2 2 4 6 8 10 10 8 6 4 2 2 1 0 - - - - - - - -
Other Operating Expenses
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - -1 -1 -1 -1 0 - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - 3 6 8 10 8 7 7 7 7 6 4 2 - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income
M -99 -104 -116 -132 -151 -161 -157 -161 -142 -126 -112 -87 -73 -61 -44 -31 -22 -15 -14 -13 -11 -10 -8 -7 -7 -7 -7 -7 -9 -9 -13 -16 -18 -19 -18 -17 -16 -12 -7 -4 0 0 0 0 0 0 0 0 0 0
Interest Expense
M 1 3 4 5 9 8 8 8 2 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 16 23 23 23 7 - - - - - - - -
Non-operating Income/Expense
M 2 1 -1 1 7 4 3 4 -2 -1 -1 -1 1 0 0 0 -1 0 -3 -4 -5 -5 -1 -1 0 1 1 1 1 1 4 13 24 25 32 -4 -40 -27 -44 -18 8 -7 - - - - 0 0 0 0
EBT
M -94 -99 -112 -129 -144 -157 -153 -157 -143 -126 -112 -86 -71 -59 -43 -30 -23 -15 -18 -17 -17 -17 -11 -9 -7 -6 -6 -6 -8 -8 -9 -3 6 6 14 -21 -57 -54 -60 -30 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M -26 -4 -5 -3 -7 -4 -3 -4 1 0 -1 -1 -2 -1 -1 -1 5 4 7 8 6 6 3 2 1 0 -1 -1 0 -1 0 -1 -1 0 0 0 0 0 0 - - - - - - - 0 0 0 0
Income after Tax
M -69 -95 -107 -126 -136 -153 -150 -152 -145 -126 -112 -86 -69 -58 -37 -21 -19 -8 -19 -23 -20 -23 -14 -11 -8 -6 -5 -6 -8 -7 -9 -2 7 6 14 -21 -27 -24 -30 - - - - - - - 0 0 0 0
Non-Controlling Interest
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - -
Net Income
M -25 -52 -90 -129 -144 -157 -153 -157 -143 -126 -112 -86 -71 -59 -43 -30 -23 -15 -18 -17 -17 -17 -11 -9 -7 -6 -6 -6 -5 -5 -6 0 0 8 8 9 -21 -27 -24 -30 0 0 0 0 0 0 - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 30,107,444.75 30,099,203.00 29,981,568.25 29,972,701.25 29,931,874.25 29,505,223.75 26,486,242.25 23,339,927.75 20,119,615.50 17,164,633.25 16,675,005.75 16,316,554.00 15,883,655.25 15,425,044.75 13,104,429.75 11,533,559.25 10,143,093.50 8,335,909.00 8,356,962.00 6,701,032.00 5,045,101.75 3,951,955.00 3,137,158.50 3,136,094.00 3,135,029.75 3,103,048.00 3,071,094.00 3,039,999.75 3,008,905.50 3,006,897.75 2,968,414.25 3,024,792.50 2,943,792.25 2,864,763.50 3,031,465.25 2,731,968.00 2,569,849.25 2,254,891.25 1,730,678.50 1,577,839.25 1,362,500.00 1,300,000.00 1,237,500.00 1,175,000.00 1,057,540.75 940,081.50 821,331.50 703,442.00 702,581.50 700,000.00
EBITDA
M -97 -103 -115 -130 -149 -156 -152 -157 -139 -124 -111 -86 -74 -61 -45 -31 -17 -11 -7 -5 -6 -6 -8 -6 -7 -7 -7 -8 -9 -10 -14 -17 -18 -19 -18 -17 -42 -38 -34 -30 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 24 1 1 2 2 5 4 3 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 0 0
EBIT
M -122 -104 -116 -132 -151 -161 -156 -160 -141 -125 -112 -86 -74 -61 -45 -31 -17 -11 -7 -5 -6 -6 -8 -6 -7 -7 -7 -8 -9 -10 -14 -17 -18 -19 -18 -17 -43 -38 -34 -30 0 0 0 0 0 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 29.20 4.02 4.73 3.15 5.30 2.65 2.01 2.61 -0.96 0.16 0.50 0.74 4.51 2.66 3.28 4.10 -49.71 -92.88 -72.04 -54.44 -37.61 -33.30 -19.98 -15.26 -3.07 5.10 15.47 14.32 10.13 18.97 8.08 9.32 11.93 0.00 0.01 0.00 0.00 0.01 -0.01 - - - - - - - 74.95 74.95 74.95 74.95
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.44 4.21 5.76 16.63 21.87 24.79 26.05 22.28 23.90 25.05 28.77 26.09 25.17
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -617.52 -634.45 -1,244.18 -1,173.84 -1,023.78 -961.63 -335.69 -446.57 -404.47 -399.39 -314.30 -8.35
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -168.86 -472.92 -1,339.73 -1,339.73 -1,342.35 -1,625.04 -176.73 -176.73 - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -436.07 -602.47 -621.72 -1,234.62 -1,169.79 -1,021.75 -961.63 -335.69 -446.57 -401.35 -395.22 -308.04 4.17
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -617.52 -634.45 -963.38 -1,131.82 -931.74 -848.87 -388.68 -446.57 -404.47 -399.39 -314.30 -8.35
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -458.06 -617.52 -634.45 -1,244.18 -1,173.84 -1,023.78 -961.63 -335.69 -446.57 -404.47 -399.39 -314.30 -8.35

StockViz Staff

September 19, 2024

Any question? Send us an email